Czepiel J, Dróżdż M, Pituch H, et al. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis. 2019;38(7):1211–21. https://doi.org/10.1007/s10096-019-03539-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schäffler H, Breitrück A. Clostridium difficile—from colonization to infection. Front Microbiol. 2018;9:646. https://doi.org/10.3389/fmicb.2018.00646.

Article  PubMed  PubMed Central  Google Scholar 

CDC. Emerging infections program healthcare-associated infections—community interface report: Clostridioides difficile infection. 2019. https://www.cdc.gov/hai/eip/pdf/cdiff/2019-CDI-Report-H.pdf. Accessed Jun 2023.

Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478–98. https://doi.org/10.1038/ajg.2013.4. (Quiz 99).

Article  CAS  PubMed  Google Scholar 

Guh AY, Mu Y, Winston LG, et al. Trends in U.S. burden of Clostridioides difficile infection and outcomes. N Engl J Med. 2020;382(14):1320–30. https://doi.org/10.1056/NEJMoa1910215.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lessa FC, Winston LG, McDonald LC. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(24):2369–70. https://doi.org/10.1056/NEJMc1505190.

Article  PubMed  Google Scholar 

CDC. Emerging infections program healthcare-associated infections—community interface report. Clostridioides difficile infection. 2018. https://www.cdc.gov/hai/eip/Annual-CDI-Report-2018.html. Accessed Jun 2023.

Cornely OA, Miller MA, Louie TJ, Crook DW, Gorbach SL. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis. 2012;55(Suppl 2):S154–61. https://doi.org/10.1093/cid/cis462.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reveles KR, Lawson KA, Mortensen EM, et al. National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014. PLoS ONE. 2017;12(12):e0189227. https://doi.org/10.1371/journal.pone.0189227.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh T, Bedi P, Bumrah K, Singh J, Rai M, Seelam S. Updates in treatment of recurrent Clostridium difficile infection. J Clin Med Res. 2019;11(7):465–71. https://doi.org/10.14740/jocmr3854.

Article  CAS  PubMed  PubMed Central  Google Scholar 

CDC. Clostridioides difficile infection (CDI) tracking. https://www.cdc.gov/hai/eip/cdiff-tracking.html. Accessed Jun 2023.

Hopkins RJ, Wilson RB. Treatment of recurrent Clostridium difficile colitis: a narrative review. Gastroenterol Rep (Oxf). 2017;6(1):21–8. https://doi.org/10.1093/gastro/gox041.

Article  PubMed  Google Scholar 

Sartelli M, Di Bella S, McFarland LV, et al. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World J Emerg Surg. 2019;14:8. https://doi.org/10.1186/s13017-019-0228-3.

Article  PubMed  PubMed Central  Google Scholar 

Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539–48. https://doi.org/10.1056/NEJMra1403772.

Article  CAS  PubMed  Google Scholar 

Abad CLR, Safdar N. A review of Clostridioides difficile infection and antibiotic-associated diarrhea. Gastroenterol Clin N Am. 2021;50(2):323–40. https://doi.org/10.1016/j.gtc.2021.02.010.

Article  Google Scholar 

Falcone M, Tiseo G, Iraci F, et al. Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes. Clin Microbiol Infect. 2019;25(4):474–80. https://doi.org/10.1016/j.cmi.2018.06.020.

Article  CAS  PubMed  Google Scholar 

Goldenberg SD, Wigglesworth N, Wade P, Price NM. Effectiveness of early use of fidaxomicin in preventing recurrence of Clostridium difficile infection. J Hosp Infect. 2019;102(3):352–3. https://doi.org/10.1016/j.jhin.2019.01.013.

Article  CAS  PubMed  Google Scholar 

DuPont HL, Garey K, Caeiro JP, Jiang ZD. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control. Curr Opin Infect Dis. 2008;21(5):500–7. https://doi.org/10.1097/QCO.0b013e32830f9397.

Article  PubMed  Google Scholar 

Hu MY, Katchar K, Kyne L, et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology. 2009;136(4):1206–14. https://doi.org/10.1053/j.gastro.2008.12.038.

Article  PubMed  Google Scholar 

Alrahmany D, Ereshefsky BJ, El Nekidy WS, Harb G, Pontiggia L, Ghazi IM. Risk factors for recurrence of Clostridioides difficile in hospitalized patients. J Infect Public Health. 2021;14(11):1642–9. https://doi.org/10.1016/j.jiph.2021.09.016.

Article  PubMed  Google Scholar 

Finn E, Andersson FL, Madin-Warburton M. Burden of Clostridioides difficile infection (CDI)—a systematic review of the epidemiology of primary and recurrent CDI. BMC Infect Dis. 2021;21(1):456. https://doi.org/10.1186/s12879-021-06147-y.

Article  PubMed  PubMed Central  Google Scholar 

Song JH, Kim YS. Recurrent Clostridium difficile infection: risk factors, treatment, and prevention. Gut Liver. 2019;13(1):16–24. https://doi.org/10.5009/gnl18071.

Article  CAS  PubMed  Google Scholar 

Zilberberg MD, Reske K, Olsen M, Yan Y, Dubberke ER. Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study. BMC Infect Dis. 2014;14:306. https://doi.org/10.1186/1471-2334-14-306.

Article  PubMed  PubMed Central  Google Scholar 

Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother. 2012;67(3):742–8. https://doi.org/10.1093/jac/dkr508.

Article  CAS  PubMed  Google Scholar 

Nathanson BH, Higgins TL, McGee WT. The dangers of extreme body mass index values in patients with Clostridium difficile. Infection. 2017;45(6):787–93. https://doi.org/10.1007/s15010-017-1036-x.

Article  CAS  PubMed  Google Scholar 

Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt). 2007;8(6):557–66. https://doi.org/10.1089/sur.2006.062.

Article  PubMed  Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9, w64. https://doi.org/10.7326/0003-4819-151-4-200908180-00135.

Article  PubMed  Google Scholar 

Jorgenson MR, Descourouez JL, Yang DY, et al. Epidemiology, risk factors, and outcomes after early posttransplant Clostridiodes difficile infection in renal transplant recipients. Ann Pharmacother. 2019;53(10):1020–5. https://doi.org/10.1177/1060028019845003.

Article  PubMed  Google Scholar 

Davis ML, Sparrow HG, Ikwuagwu JO, Musick WL, Garey KW, Perez KK. Multicentre derivation and validation of a simple predictive index for healthcare-associated Clostridium difficile infection. Clin Microbiol Infect. 2018;24(11):1190–4. https://doi.org/10.1016/j.cmi.2018.02.013.

Article  CAS  PubMed  Google Scholar 

Eberly MD, Susi A, Adams DJ, Love CS, Nylund CM. Epidemiology and outcomes of patients with healthcare facility-onset Clostridioides difficile infection. Mil Med. 2022;187(7–8):e915–20. https://doi.org/10.1093/milmed/usab116.

Article  PubMed  Google Scholar 

Harris AD, Sbarra AN, Leekha S, et al. Electronically available comorbid conditions for risk prediction of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol. 2018;39(3):297–301. https://doi.org/10.1017/ice.2018.10.

Article  PubMed  PubMed Central  Google Scholar 

Lee DU, Fan GH, Ahern RR, Karagozian R. The effect of malnutrition on the infectious outcomes of hospitalized patients with cirrhosis: analysis of the 2011–2017 hospital data. Eur J Gastroenterol Hepatol. 2021;32(2):269–78. https://doi.org/10.1097/meg.0000000000001991.

Article  PubMed  Google Scholar 

Lorden AL, Jiang L, Radcliff TA, Kelly KA, Ohsfeldt RL. Potentially preventable hospitalizations and the burden of healthcare-associated infections. Health Serv Res Manag Epidemiol. 2017;4:2333392817721109. https://doi.org/10.1177/2333392817721109.

Article  PubMed  PubMed Central  Google Scholar 

Miller AC, Sewell DK, Segre AM, Pemmaraju SV, Polgreen PM. Risk for Clostridioides difficile infection among hospitalized patients associated with multiple healthcare exposures prior to admission. J Infect Dis. 2021;224(4):684–94. https://doi.org/10.1093/infdis/jiaa773.

Article  PubMed  Google Scholar 

Press A, Ku B, McCullagh L, Rosen L, Richardson S, McGinn T. Developing a clinical prediction rule for first hospital-onset Clostridium difficile infections: a retrospective observational study. Infect Control Hosp Epidemiol. 2016;37(8):896–900. https://doi.org/10.1017/ice.2016.97.

Article  PubMed  Google Scholar 

Root ED, Lindstrom M, Xie A, Mangino JE, Moffatt-Bruce S, Hebert C. Investigating the association of room features with healthcare-facility-onset Clostridioides difficile: an exploratory study. Infect Control Hosp Epidemiol. 2021;42(7):847–52. https://doi.org/10.1017/ice.2020.1307.

Article